Atherogenic lipid phenotype in a general group of subjects.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Archives of Pathology & Laboratory Medicine

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1043/1543-2165(2007)131[1679:ALPIAG]2.0.CO;2PMID 17979486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increasing prevalence of the metabolic syndrome among u.s. Adults.

  2004cited by this paper
• Atherogenic Lipid Phenotype and Lipoprotein (a) in Diabetes

  2002cited by this paper
• Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes.

  2002cited by this paper
• Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes

  2002cited by this paper
• Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus.

  2002cited by this paper
• Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds.

  2002cited by this paper
• Gestational diabetes mellitus in women of single gravidity in Tianjin City, China.

  2002cited by this paper
• Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200

  2002cited by this paper
• Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

  2001cited by this paper
• Distribution and correlates of high-density lipoprotein subclasses among children and adolescents.

  2001cited by this paper
• Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects.

  2001cited by this paper
• Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.

  2000cited by this paper
• Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.

  1999cited by this paper
• Optimization of Glycemic Control by Insulin Therapy Decreases the Proportion of Small Dense LDL Particles in Diabetic Patients

  1997cited by this paper
• LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women.

  1997cited by this paper
• Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

  1997cited by this paper
• Lipoprotein heterogeneity and apolipoprotein B metabolism.

  1997cited by this paper
• Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.

  1996cited by this paper
• A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

  1996cited by this paper
• Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women.

  1995cited by this paper
• Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women.

  1995cited by this paper
• Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.

  1994cited by this paper
• LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women

  1993cited by this paper
• Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.

  1993cited by this paper
• Detection and quantitation of LDL subfractions

  1992cited by this paper
• High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

  1991cited by this paper
• Identification of multiple subclasses of plasma low density lipoproteins in normal humans.

  1982cited by this paper

• Phytonutrients of Bitter Apricot Seeds Modulate Human Lipid Profile and LDL Subfractions in Adults with Elevated Cholesterol Levels

  2022cites this paper
• A pilot study on pattern B lipoprotein profile in Malaysia.

  2020cites this paper
• Gender differences in LDL and HDL subfractions in atherogenic and nonatherogenic phenotypes.

  2020cites this paper
• Effect of berries/apple mixed juice consumption on the positive modulation of human lipid profile

  2019cites this paper
• Gender differences in LDL- and HDL-cholesterol subfractions in patients after the acute ischemic stroke and their association with oxidative stress markers

  2018cites this paper
• Metabolic and Clinical Significance of Diabetes Mellitus Type 2; Implication for Rising Prevalence in Nigeria

  2018cites this paper
• Association of lipoprotein subfractions with endothelial function and arterial stiffness in acute ischemic stroke

  2017cites this paper
• The Interaction between CETP Taq1B Polymorphism and Dietary Fat Intake on HDL-c according to lipid profile status in T2DM Patients

  2016cites this paper
• Effect of lifestyle modification on blood lipid levels in Maeka Sub-district population, Sanpatong District, Chiang Mai Province

  2016cites this paper
• ارتباط متقابل پلی مورفیسمCETP Taq1Bو مقدار چربی دریافتیبر سطحHDL-cبا توجه به وضعیت پروفایل لیپیددر افراد مبتلا به دیابت نوع 2

  2016cites this paper
• The Assessment of the Atherogenic Lipoprotein Profile in Cardiovascular Diseases by Lipoprint System Analysis

  2015cites this paper
• Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: A study in San Luis, Argentina

  2014cites this paper
• The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism

  2014cites this paper
• Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. is there a need to change our approach to diagnosing dyslipidemia?

  2014cites this paper
• High-density lipoprotein profile in newly-diagnosed lower extremity artery disease in Slovak population without diabetes mellitus.

  2014cites this paper
• Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients

  2013cites this paper
• Distribution of low-density lipoprotein and high-density lipoprotein subclasses in patients with sarcoidosis.

  2013cites this paper
• A Non-Atherogenic and Atherogenic Lipoprotein Profile in Individuals with Dyslipoproteinemia

  2012cites this paper
• New molecular insights into CETP structure and function: a review

  2012cites this paper
• Size of low‑density lipoprotein particles in patients after stroke.

  2012cites this paper
• Atherogenic normolipidemia - a new phenomenon in the lipoprotein profile of clinically healthy subjects.

  2011cites this paper
• HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.

  2011cites this paper
• Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.

  2011cites this paper
• Lipoprotein profile in patients who survive a stroke.

  2011cites this paper
• Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension.

  2011cites this paper
• Hyper-betalipoproteinemia LDL 1,2: a newly identified nonatherogenic hypercholesterolemia in a group of hypercholesterolemic subjects.

  2011cites this paper